BridgeMD
Frozen shoulder – can physiotherapy improve the outcome?
EU CTIS ID: 2024-519728-26-00
What this study is testing
There is a need for high-quality studies evaluating the effectiveness of physiotherapy combined with intra-articular corticosteroid injections for improving shoulder function in patients with frozen shoulder. We aim to compare the effectiveness of physical therapy, corticosteroid injections, and their combination, on pain and function at 3 months in patients with frozen shoulder.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. Shoulder pain <9 months 2. Reduced passive range of movement in the glenohumeral joint compared with the unaffected side, more than 30 degrees for at least two of these three movements: forward flexion, abduction or external rotation. 3. Shoulder pain intensity >3 on a scale from 0 (no pain) to 10 (worst possible pain) in either activity or rest (including night) 4. Age 18 to 70 years 5. Capable of giving signed informed consent as described in Appendix 1 which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
You likely can't join if
- 1.Shoulder joint osteoarthritis 2. Bleeding disorders 3. Active cancer or infectious disease 4.Serious psychiatric or neurological disorder 5. Using corticosteroid tablets for other medical conditions 6. Prior corticosteroid injection for frozen shoulder in the affected shoulder
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.